Dian Diagnostics Group Co.,Ltd.
300244.SZ
Get informed when a big investor buys or sells
+ FollowMarket Cap$10.67B
Close$
$27.34
28.4% upside
Current Fair Value
28.4% upsideUndervalued by 28.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $10.67 Billion |
|---|---|
| Enterprise Value | $11.65 Billion |
| Dividend Yield | $0.35 (1.62%) |
| Earnings per Share | $0.07 |
| Beta | 0.69 |
| Outstanding Shares | 611,099,436 |
Return
| Return on Equity | 7.24% |
|---|---|
| Return on Assets | 3.38% |
| Return on Invested Capital | 8.52% |
Valuation & Multiples
| P/E Ratio | 28.16 |
|---|---|
| PEG | 6.43 |
| Price to Sales | 1.33 |
| Price to Book Ratio | 1.52 |
| Enterprise Value to Revenue | 1.17 |
| Enterprise Value to EBIT | 13.69 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.2 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
October 20, 2026
EPS Estimate
$0.20
Average shareholder expectationRevenue Estimate
$2.75 B
Average shareholder expectationNext Earnings Call
Expected Date
April 9, 2027
EPS Estimate
$0.06
Average shareholder expectationRevenue Estimate
$2.86 B
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Dian Diagnostics Group Co.,Ltd.
7,462 employees
CEO: Haibin Chen Dian Diagnostics Group Co.,Ltd. operates as a leading independent provider of medical diagnostic services within China. The company delivers comprehensive diagnostic solutions to a broad spectrum of healthcare organizations, including ge...